| Stage | BRK-B | % of rev | SKWD | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $102B | 100.00% | $455M | 100.00% | BRK-B ×223.59 |
| Gross profit | $55.9B | 54.87% | $200M | 43.97% | BRK-B +10.9pp |
| Operating income | $17.1B | 16.77% | $73M | 16.12% | BRK-B +0.7pp |
| Pre-tax income | $31.8B | 31.25% | $64M | 13.98% | BRK-B +17.3pp |
| Net income | $25.8B | 25.31% | $50M | 10.94% | BRK-B +14.4pp |
| Stage | BRK-B | SKWD | Gap · A − B |
|---|---|---|---|
| Revenue | $102B100.00% | $455M100.00% | BRK-B ×223.59 |
| Gross profit | 54.87%$55.9B | 43.97%$200M | BRK-B +10.9pp |
| Operating income | 16.77%$17.1B | 16.12%$73M | BRK-B +0.7pp |
| Pre-tax income | 31.25%$31.8B | 13.98%$64M | BRK-B +17.3pp |
None
No disclosed counterparties: BRK-B.
| Net income |
| 25.31%$25.8B |
| 10.94%$50M |
| BRK-B +14.4pp |